Gitman Paul 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Aug 29, 2018
Insider Transaction Report
Form 4
Gitman Paul
Director
Transactions
- Sale
Common Stock, $0.001 par value
2018-08-27$50.11/sh−10,000$501,144→ 30,000 total - Sale
Common Stock, $0.001 par value
2018-08-28$48.88/sh−5,000$244,416→ 25,000 total - Sale
Common Stock, $0.001 par value
2018-08-29$49.79/sh−5,000$248,973→ 20,000 total
Footnotes (3)
- [F1]The selling price of $50.1144 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.23 to $52.19. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]The selling price of $48.8831 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $48.68 to $49.41. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The selling price of $49.7946 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.35 to $50.00. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.